Thomas Simmet
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Medicinal Plants
- Immunology top 1%
- T-cell and B-cell Immunology
Papers in
- Pharmacology 65
- Inflammatory mediators and NSAID effects 35
- Pharmacological Effects of Medicinal Plants 27
- Biochemistry 41
- Eicosanoids and Hypertension Pharmacology 41
- Co-authors
- Tatiana Syrovets (105 shared papers)Berthold Büchele (36 shared papers)Oleg Lunov (26 shared papers)Mustapha Rouis (13 shared papers)Gerd Ulrich Nienhaus (16 shared papers)Volker Mailänder (12 shared papers)Katharina Landfester (12 shared papers)Khadija El Hadri (8 shared papers)
- Journals
- The FASEB Journal (11 papers)Blood (10 papers)Biomaterials (7 papers)The Journal of Immunology (7 papers)European Journal of Pharmacology (7 papers)
- Partner nations
- GermanyUnited StatesEgypt
In The Last Decade
Thomas Simmet
242 papers receiving 15.8k citations
Thomas Simmet's Hit Papers
Peers
Comparison fields: 5 of 151
- Pharmacology 1.6k
- Immunology 1.8k
- Epidemiology 2.9k
- Biomaterials 1k
- Cancer Research 928
Countries citing papers authored by Thomas Simmet
This map shows the geographic impact of Thomas Simmet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Simmet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Simmet more than expected).
Fields of papers citing papers by Thomas Simmet
This network shows the impact of papers produced by Thomas Simmet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Simmet. The network helps show where Thomas Simmet may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Simmet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 248 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Hit paper breakdown → | 2016 | 4680 |
| 2 | NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases Hit paper breakdown → | 2015 | 626 |
| 3 | 2011 | 540 | |
| 4 | 2013 | 294 | |
| 5 | 2016 | 286 | |
| 6 | 2012 | 265 | |
| 7 | 2011 | 236 | |
| 8 | 2014 | 208 | |
| 9 | 2003 | 202 | |
| 10 | 2012 | 184 | |
| 11 | 2016 | 184 | |
| 12 | 1986 | 175 | |
| 13 | 2010 | 175 | |
| 14 | 2000 | 166 | |
| 15 | 2015 | 163 | |
| 16 | 2005 | 162 | |
| 17 | 2002 | 155 | |
| 18 | 2004 | 154 | |
| 19 | 2007 | 153 | |
| 20 | 2009 | 153 |
About Thomas Simmet
Thomas Simmet is a scholar working on Pharmacology, Biochemistry, Immunology, Hematology and Biomaterials, having authored 248 papers that have together received 16.2k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (41 papers), Inflammatory mediators and NSAID effects (35 papers), Pharmacological Effects of Medicinal Plants (27 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers), Nanoparticle-Based Drug Delivery (16 papers), Atherosclerosis and Cardiovascular Diseases (11 papers), Natural product bioactivities and synthesis (9 papers) and Complement system in diseases (8 papers). The work is most often cited by research in Pharmacology (1.6k citations), Immunology (1.8k citations), Epidemiology (2.9k citations), Biomaterials (1k citations) and Cancer Research (928 citations). Thomas Simmet has collaborated with scholars based in Germany, United States and Egypt. Frequent co-authors include Tatiana Syrovets, Berthold Büchele, Oleg Lunov, Mustapha Rouis, Gerd Ulrich Nienhaus, Volker Mailänder, Katharina Landfester, Khadija El Hadri, Amna Abderrazak and Cornelia Loos. Their work appears in journals such as The FASEB Journal, Blood, Biomaterials, The Journal of Immunology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.